CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 54  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1090
LYS 10.0120
GLU 20.0074
LEU 30.0105
ARG 40.0117
CYS 50.0094
GLN 60.0203
CYS 70.0273
ILE 80.0731
LYS 90.0404
THR 100.0233
TYR 110.0222
SER 120.0252
LYS 130.0339
PRO 140.0453
PHE 150.0343
HIS 160.0281
PRO 170.0195
LYS 180.0384
PHE 190.0215
ILE 200.0123
LYS 210.0159
GLU 220.0206
LEU 230.0132
ARG 240.0142
VAL 250.0096
ILE 260.0078
GLU 270.0169
SER 280.0153
GLY 290.0092
PRO 300.0108
HIS 310.0102
CYS 320.0067
ALA 330.0129
ASN 340.0081
THR 350.0191
GLU 360.0107
ILE 370.0121
ILE 380.0143
VAL 390.0145
LYS 400.0246
LEU 410.0145
SER 420.0094
ASP 430.0340
GLY 440.0199
ARG 450.0227
GLU 460.0264
LEU 470.0127
CYS 480.0122
LEU 490.0098
ASP 500.0189
PRO 510.0203
LYS 520.0197
GLU 530.0142
ASN 540.0263
TRP 550.0185
VAL 560.0126
GLN 570.0173
ARG 580.0155
VAL 590.0102
VAL 600.0047
GLU 610.0045
LYS 620.0022
PHE 630.0081
LEU 640.0183
LYS 650.0199
ARG 660.0181
ALA 670.0141
GLU 680.1090
ASN 690.0741

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.